This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Precigen, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Amy Wesa: Innovator in Cancer Therapy
Introduction
Amy Wesa is a prominent inventor based in Blacksburg, Virginia, known for her significant contributions to cancer therapy. She has developed innovative solutions that aim to improve treatment outcomes for patients suffering from proliferative disorders.
Latest Patents
Amy Wesa holds one patent titled "ROR-1 specific chimeric antigen receptors and uses thereof." This patent provides chimeric antigen receptors (CARs) specifically designed for cancer therapy. The CARs contain a single-chain variable fragment (scFv) derived from an anti-ROR-1 monoclonal antibody. The patent also details immune effector cells that incorporate these CARs and outlines methods for treating various proliferative disorders.
Career Highlights
Wesa's career is marked by her dedication to advancing cancer treatment through innovative research and development. She is currently associated with Precigen, Inc., where she continues to work on groundbreaking therapies that leverage her expertise in immunology and cellular engineering.
Collaborations
Amy collaborates with notable colleagues, including Rutul R Shah and ChangHung Chen, to further enhance the impact of her research in the field of cancer therapy.
Conclusion
Amy Wesa's work exemplifies the vital role of innovation in the fight against cancer. Her contributions through patents and collaborations are paving the way for new therapeutic approaches that could significantly benefit patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
